INJ just reached another major milestone. For the first time in Asia, investors can now gain exposure to @injective through a regulated investment fund. Merkle Capital has launched M-INJ, a Thailand SEC supervised fund that gives both retail and institutional investors access to INJ without needing to manage wallets, custody assets, or create exchange accounts. This is bigger than just a new investment product. Over the past few months, Injective has been steadily expanding its presence across regulated financial markets. In the US, INJ futures are already trading on @Bitnomial, a CFTC regulated exchange, placing INJ alongside a small group of digital assets with regulated futures markets. At the same time, ETF applications tied to INJ are progressing in the United States, while Injective has also established a policy presence in Washington through the Injective Policy Institute. Now, with M-INJ live in Thailand, regulated access to INJ extends into Asia as well. The launch addresses one of the biggest barriers for traditional investors: access. Instead of dealing with self custody, wallets, and exchange accounts, investors can gain exposure to INJ through a regulated structure managed by a licensed asset manager. What makes this especially notable is that Merkle Capital rarely creates single asset funds outside of Bitcoin focused strategies. Its decision to launch a dedicated INJ fund reflects growing confidence in Injective's position as a blockchain built specifically for finance. As tokenization and real world assets continue moving onchain, Injective is increasingly being viewed as infrastructure designed for that future. Combined with INJ's deflationary token model and expanding institutional adoption, the regulated investment case around the asset continues to strengthen. With regulated futures in the US, active ETF filings, and now a regulated fund in Asia, INJ is becoming one of the few digital assets building a presence across multiple regulated markets around the world. injective-protocol:native